Safety and Efficacy of Diquafosol Compared to Artificial Tears for the Treatment of Dry Eye: A Systematic Review and Meta-Analysis
International Journal of Molecular Sciences · 22.08.2025 · 26 (17) · 8113
DOI: 10.3390/ijms26178113 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 22.08.2025. Verfasst von José Gerardo Serrano-Robles und 6 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Oftalmologia Fundacion Conde de Valenciana IAP, Mexico City 11520, Mexico. Hauptthemen laut MEDLINE: Uracil Nucleotides, Polyphosphates, Dry Eye Syndromes, Lubricant Eye Drops. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Dry eye disease (DED) is a prevalent and disabling condition. Artificial tears are commonly used but often inadequate for moderate-to-severe cases. Secretagogues such as pilocarpine, cevimeline, and diquafosol offer potential alternatives, though their comparative effectiveness remains unclear. To evaluate the safety and efficacy of these secretagogues versus artificial tears in adults with DED, we searched CENTRAL, PubMed, Scopus, LILACS, ClinicalTrials.gov, and WHO ICTRP without language restrictions. Randomized controlled trials (RCTs) comparing secretagogues to artificial tears were eligible. Data extraction and synthesis were conducted using Covidence and the Cochrane RoB 2 tool, and 19 RCTs (n = 2697) were included. Fifteen were analyzed quantitatively; however, only eight trials evaluating diquafosol were suitable for meta-analysis, as data for pilocarpine and cevimeline were insufficient for quantitative synthesis. GRADE was used to assess evidence certainty. PROSPERO registration: CRD42020218407. Diquafosol significantly improved rose bengal staining at 4 weeks and OSDI scores and TBUT in post-cataract patients at 4 and 12 weeks. However, it increased mild adverse events (RR, 1.81; 95% CI, 1.15–2.84). Evidence for pilocarpine and cevimeline was limited. Diquafosol 3% shows greater efficacy than artificial tears in post-cataract DED but with more side effects. Further research is needed for other secretagogues.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Oftalmologia Fundacion Conde de Valenciana IAP, Mexico City 11520, Mexico.
- Centro de Investigación en Ciencias de La Salud Anáhuac (CICSA), Facultad de Ciencias de La Salud, Universidad Anáhuac México, Campus Norte, Mexico City 52786, Mexico.
ORCID-Profile: José Gerardo Serrano-Robles, Ana Karen Pérez-Vázquez, Guillermo Raul Vera-Duarte, Alejandro Navas, Arturo Ramirez-Miranda, Enrique O Graue-Hernandez, Nicolás Kahuam-López
Zitieren
APA
Serrano-Robles, J. G., Pérez-Vázquez, A. K., Vera-Duarte, G. R., Navas, A., Ramirez-Miranda, A., Graue-Hernandez, E. O., & Kahuam-López, N. (2025). Safety and Efficacy of Diquafosol Compared to Artificial Tears for the Treatment of Dry Eye: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences, 26(17), 8113. https://doi.org/10.3390/ijms26178113
Vancouver
Serrano-Robles JG, Pérez-Vázquez AK, Vera-Duarte GR, Navas A, Ramirez-Miranda A, Graue-Hernandez EO, et al. Safety and Efficacy of Diquafosol Compared to Artificial Tears for the Treatment of Dry Eye: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. 2025;26(17):8113. doi:10.3390/ijms26178113
BibTeX
@article{SerranoRobles2025,
author = {Serrano-Robles, José Gerardo and Pérez-Vázquez, Ana Karen and Vera-Duarte, Guillermo Raul and Navas, Alejandro and Ramirez-Miranda, Arturo and Graue-Hernandez, Enrique O and Kahuam-López, Nicolás},
title = {Safety and Efficacy of Diquafosol Compared to Artificial Tears for the Treatment of Dry Eye: A Systematic Review and Meta-Analysis},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {17},
pages = {8113},
doi = {10.3390/ijms26178113}
}
EUVIMED